Comparison Between CT Volumetry and Extracellular Volume Fraction Using Liver Dynamic CT for the Predictive Ability of Liver Fibrosis in Patients with Hepatocellular Carcinoma
Overview
Authors
Affiliations
Objectives: To compare the predictive ability of liver fibrosis (LF) by CT-volumetry (CTV) for liver and spleen and extracellular volume fraction (ECV) for liver in patients undergoing liver resection.
Methods: We retrospectively analysed 90 consecutive patients who underwent CTV and ECV. Manually placed region-of-interest ECV (manual-ECV), rigid-registration ECV (rigid-ECV), and nonrigid-registration ECV (nonrigid-ECV) were calculated as ECV(%) = (1-haematocrit) × (ΔHU/ΔHU), where ΔHU = subtraction of unenhanced phase from equilibrium phase (240 s). Manual-ECV was compared with CTV for the estimation of LF. The total liver volume to body surface area (TLV/BSA), splenic volume to BSA (SV/BSA), ratio of TLV to SV (TLV/SV), ratio of right liver volume to SV (RV/SV), and liver segmental volume ratio (LSVR) were measured. ROC analyses were performed for ECV and CTV.
Results: After excluding 10 patients, seventy-eight (97.5%) out of 80 patients had a Child-Pugh score of 5 points, and two (2.5%) patients had a Child-Pugh score of 6 points. AUC of ECV showed no significant difference among manual-ECV, rigid-ECV, and nonrigid-ECV. TLV/BSA, SV/BSA, TLV/SV, and RV/SV had a higher correlation with LF grades than manual-ECV. AUC of SV/BSA was significantly higher than that of manual-ECV in F0-1 vs F2-4 and F0-2 vs F3-4. AUC of SV/BSA (0.76-0.83) was higher than that of manual-ECV (0.61-0.75) for all LF grades, although manual-ECV could differentiate between F0-3 and F4 at high AUC (0.75).
Conclusions: In patients undergoing liver resection, SV/BSA is a better method for estimating severe LF grades, although manual-ECV has the ability to estimate cirrhosis (≥ F4).
Key Points: The splenic volume is a better method for estimating liver fibrosis grades. The extracellular volume fraction is also a candidate for the estimation of severe liver fibrosis.
Nagayama Y, Hokamura M, Taguchi N, Yokota Y, Osaki T, Ogasawara K Eur Radiol. 2025; .
PMID: 40080190 DOI: 10.1007/s00330-025-11497-1.
Song Q, Li Y, Wu T, Hu W, Liu Y, Liu A Abdom Radiol (NY). 2024; .
PMID: 39665991 DOI: 10.1007/s00261-024-04752-4.
Sun M, Ma S, Tang G, Deng W, Peng Y, Yu S Abdom Radiol (NY). 2024; .
PMID: 39511028 DOI: 10.1007/s00261-024-04681-2.
Wu Y, Li J, Ding L, Huang J, Chen M, Li X Cancer Imaging. 2024; 24(1):146.
PMID: 39456114 PMC: 11515807. DOI: 10.1186/s40644-024-00793-6.
Nakazawa Y, Okada M, Tago K, Kuwabara N, Mizuno M, Abe H Eur Radiol. 2024; 35(3):1464-1472.
PMID: 39349724 DOI: 10.1007/s00330-024-11086-8.